OGT and colorectal carcinoma: Consistent with our data using OGTshRNA in HCT116 cells, the inhibition of OGT by OSMI-1 leads to a dose-dependent decrease in cyclin D and increase in cleaved PARP in primary Pt130 and Pt93 CRC cells (Supplemental Figure S4).